Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
LKQ Corporation Announces Results For Third Quarter 2026
-
Hilton Grand Vacations Reports Third Quarter 2026 Results
-
Blue Owl Capital Inc. Third Quarter 2026 Results
-
Oshkosh Corporation Reports 2026 Third Quarter Results
-
Incyte Reports Third Quarter 2026 Financial Results and Provides Business Updates
-
Builders FirstSource Reports Third Quarter 2026 Results
-
WEC Energy Group reports third-quarter results
-
Republic Airways Announces Third Quarter 2026 Financial Results
-
TriNet Announces Third Quarter 2026 Results and Now Expects to Deliver Earnings at the Top End of Earnings per Share Guidance Range
-
Novocure Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance
-
Altria Reports 2026 Third-Quarter and Nine-Months Results; Announces Expanded Share Repurchase Program; Raises 2026 Full-Year Earnings Guidance
-
Myers Industries Announces 2026 Third Quarter Results
-
TPG Reports Third Quarter 2026 Results
-
Upbound Group, Inc. Reports Third Quarter 2026 Results
-
Tradeweb Reports Third Quarter 2026 Financial Results
-
T. ROWE PRICE GROUP REPORTS THIRD QUARTER 2026 RESULTS
-
Quantum XChange Warns AI Systems Face Growing Quantum Security Threat as Adversaries Harvest Encrypted Data
-
CRITEO APPOINTS JIANCHANG "JC" MAO TO ITS BOARD OF DIRECTORS
-
LiveWire Group, Inc. Reports 2026 Third Quarter Financial Results
-
Bandwidth Announces Third Quarter 2026 Financial Results
-
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
-
Angel Announces “The Angel Promise,” Deepening Commitment to Values-Driven Entertainment
-
Certified-PEP Publishes 2026 Research Peptide Supplier Comparison
-
Blackstone Mortgage Trust Reports Third-Quarter 2026 Results
-
Dream Finders Homes Announces Third Quarter 2026 Results
-
Frontier Medicines Announces FDA Allowance to Proceed Under an IND for FMC-242, a Novel Covalent Allosteric PI3Kα-RAS Breaker, in Patients with Select Advanced Solid Tumors
-
Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer
-
Stratasys Conference Call to Discuss Third Quarter 2026 Financial Results
-
A2Z Cust2Mate Announces Timing of Third Quarter 2026 Earnings Release and Conference Call
-
Cognitive Credit Launches DealConnect: The Complete Workflow Solution for Restricted Deal Credit Analysis
-
Open Enrollment Is Here: What New Mexicans Should Know When Choosing 2027 Health Coverage
-
UNIFI®, Makers of REPREVE®, Completes Sale of Non-Strategic U.S. Real Estate for Gross Proceeds of $60 Million
-
Brixton Biosciences Announces Pivotal Clinical Data for Reneurx™ Nerve-Selective Therapy in Knee Osteoarthritis to be Presented at AAHKS 2026
-
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
-
Advisory List Examines Who Is Buying Accounting Firms and What It Means for Owners
-
Base.com Recognized in the 2026 Gartner® Magic Quadrant™ for Product Information Management Solutions
-
TelevisaUnivision Announces Third Quarter 2026 Results
-
New Jersey Resources Schedules Fiscal 2026 Fourth Quarter and Year-End Earnings Call
-
Bites Raises $40M Series A to Turn Frontline Training into a Business Performance Engine
-
Open Enrollment Is Here: What Texans Should Know When Choosing 2027 Health Coverage
-
RedBird Capital Partners and Guy Oseary’s Sound Ventures Announce $1 Billion Strategic Partnership
-
Bausch + Lomb Announces Publication of Multinational Survey Results Highlighting the Burden of Dry Eye Symptoms and Opportunities for Improved Awareness and Patient Education
-
Sound Point Meridian Capital, Inc. Schedules Second Fiscal Quarter Ended September 30, 2026 Earnings Release and Conference Call
-
Cosm Medical Achieves Reimbursement Pathway Milestone: US CPT® Codes Recognize the Work Behind Personalized Pessaries
-
Aircall Co-Founder Olivier Pailhès Returns as CEO
-
National Vision Holdings, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call
-
Valvoline Inc. to Report Financial Results for Fourth Quarter 2026 and Host Webcast on November 19
-
Tilray Brands Announces Next Phase of Beverage Transformation
-
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
